Last reviewed · How we verify
Melissa
At a glance
| Generic name | Melissa |
|---|---|
| Sponsor | Universidade Federal do Rio de Janeiro |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome (NA)
- Quality of Life in Diarrhea-predominant Irritable Bowel Syndrome Taking GABA (NA)
- A Clinical Trial to Investigate the Safety and Efficacy of Bloat on Gas and Bloating in Healthy Women (NA)
- Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and Adults (NA)
- Efficacy of the Nurtured Heart Approach to Reduce ADHD Behaviors in Children (NA)
- Evaluation of a Dietary Supplement Containing Melissa Officinalis Formulated in Phospholipids on Mood Well-being and Cortisol Modulation (NA)
- The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia (PHASE4)
- Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |